Skip to main content
Equibles

JPMORGAN CHASE & CO

Position in CGEM — Cullinan Therapeutics, Inc.

CIK 19617 NEW YORK, NY
Back to CGEM Full portfolio

Position in CGEM

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$5,146,708
+$923,057 QoQ
Shares Held
282,631
-4.9% QoQ
Ownership
0.439%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 183 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 82% Shared 0% None 18%

Common Shares in CGEM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,940,254,031 across 424 Biotechnology names. CGEM ranks #113 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,517,600 $3,237,487,438
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,774,199 $2,353,364,036
3 INSM
INSMED Inc
 10,428,170 $1,111,851,478
4 ALNY
Alnylam Pharmaceuticals, Inc.
 2,675,517 $805,410,876
5 RVMD
Revolution Medicines, Inc.
 3,298,066 $617,661,794
6 RYTM
Rhythm Pharmaceuticals, Inc.
 2,652,746 $294,534,385
7 JAZZ
Jazz Pharmaceuticals plc
 1,160,786 $279,714,596
8 QURE
uniQure N.V.
 4,867,755 $224,208,791

All Filings in CGEM

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,146,708 282,631
2026-03-31 $4,223,651 297,231
2025-12-31 $1,522,017 147,055
2025-09-30 $188,975 31,868
2025-06-30 $730,927 97,069
2025-03-31 $329,649 43,547
2024-12-31 $2,414,244 198,214
2024-09-30 $487,300 29,110
2024-06-30 $405,793 23,268
2024-03-31 $331,768 19,470
2023-12-31 $256,716 25,193
2023-09-30 $220,041 24,314
2023-06-30 $222,505 20,679
2023-03-31 $227,545 22,243
2022-12-31 $203,731 19,385
2022-09-30 $255,232 19,909
2022-06-30 $230,695 17,995
2022-03-31 $253,079 24,172
2021-12-31 $309,478 20,057
2021-09-30 $341,686 15,139
2021-06-30 $209,193 8,124
2021-03-31 $1,591,834 38,201